The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK.
Nat Metab. 2022 Oct;4(10):1369-1401. doi: 10.1038/s42255-022-00640-7. Epub 2022 Oct 10.
Nat Metab. 2022.
PMID: 36217034
Free PMC article.